Securin is overexpressed in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Securin is overexpressed in breast cancer

Published:2005-04-22 Issue:7 Volume:18 Page:985-990
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Ogbagabriel Selam,Fernando Manory,Waldman Frederic M,Bose Shikha,Heaney Anthony P

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800382.pdf

Reference35 articles.

1. Greenlee R, Hill-Harmon MB, Murray T, et al. Cancer Statistics, 2001. CA Cancer J Clin 2001;51:15–36.

2. Allred DC, Mohsin SK, Fuqua SA . Histological and biological evolution of human premalignant breast disease. Endocr Rel Cancer 2001;8:47–61.

3. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-I Study. J Natl Cancer Inst 1998;90:1371–1388.

4. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. JAMA 1999;281:2189–2197.

5. Sommer S, Fuqua SA . Estrogen receptor and breast cancer. Semin Cancer Biol 2001;11:339–352.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An autonomous mathematical model for the mammalian cell cycle;Journal of Theoretical Biology;2023-07

2. Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset;Medicine;2022-09-16

3. Full and D-BOX-Deficient PTTG1 Isoforms: Effects on Cell Proliferation;Molecular Biology;2022-08-30

4. Simvastatin Suppresses Human Breast Cancer Cell Invasion by Decreasing the Expression of Pituitary Tumor-Transforming Gene 1;Frontiers in Pharmacology;2020-11-04

5. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients;International Journal of Medical Sciences;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3